FBRX - Forte Biosciences, Inc.
IEX Last Trade
16
-0.760 -4.750%
Share volume: 72,645
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$16.76
-1.78
-0.10%
Summary score
11%
Profitability
8%
Dept financing
7%
Liquidity
58%
Performance
3%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-82.41%
Return on assets
-25.37%
Return on sales
0%
Return on invested capital
728.62%
Total debt ratio
20.24%
Debt ratio change over timeo
-0.91%
Current Ratio
7.17%
Quick Ratio
8.58%
Cash Position Ratio
6.87%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-34.97%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
29.11%
Debt ratio change over timeo
-0.93%
Current Ratio
5.76%
Quick Ratio
0%
Cash Position Ratio
5.52%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-23.18%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
10.41%
Debt ratio change over time
-0.97%
Current Ratio
9.45%
Quick Ratio
0%
Cash Position Ratio
9.14%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-137.17%
Return on assets
-113.57%
Return on sales
0%
Return on invested capital
339%
Total debt ratio
-91.43%
Debt ratio change over time
-0.91%
Current Ratio
3.72%
Quick Ratio
6.97%
Cash Position Ratio
3.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FBRX | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -82.41% | 13.03% | 18.15% | 6.63% |
| Return on assets | -25.37% | 2.28% | 3.22% | 5.84% |
| Return on sales | 0% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | 728.62% | 2.07% | 5.53% | 34.89% |
| Profitability | 25% | 44% | 57% | 60% |
| Total debt ratio | 20.24% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | -0.91% | 435.59% | 17.23% | -0.06% |
| Dept financing | 6% | 50% | 26% | 7% |
| Current Ratio | 5.76% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 5.52% | 0.31% | 0.49% | 2.77% |
| Liquididy | 75% | 6% | 14% | 38% |
| Short-term ratios | FBRX | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 5.91% |
| Return on assets | -34.97% | 1.6% | 2.14% | 4.97% |
| Return on sales | 0% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | 0% | 0% | 0% | 23.7% |
| Profitability | 0% | 23% | 22% | 100% |
| Total debt ratio | 29.11% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | -0.93% | 0% | 0% | -0.62% |
| Dept financing | 8% | 25% | 50% | 6% |
| Current Ratio | 5.76% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 5.52% | 0.31% | 0.49% | 2.77% |
| Liquididy | 50% | 10% | 16% | 53% |